Johnson & Johnson reported higher profits for the second quarter of 2021, buoyed by higher medical device sales and sales of its COVID-19 vaccine.
Johnson & Johnson reported higher profits for the second quarter of 2021, buoyed by higher medical device sales and sales of its COVID-19 vaccine.